These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28433580)

  • 1. Description of a novel multiplex avidity assay for evaluating HPV antibodies.
    Brady AM; Unger ER; Panicker G
    J Immunol Methods; 2017 Aug; 447():31-36. PubMed ID: 28433580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and application of a GuHCl-modified ELISA to measure the avidity of anti-HPV L1 VLP antibodies in vaccinated individuals.
    Dauner JG; Pan Y; Hildesheim A; Kemp TJ; Porras C; Pinto LA
    Mol Cell Probes; 2012 Apr; 26(2):73-80. PubMed ID: 22285687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of HPV-specific antibody responses induced by infection and vaccination: cross-reactivity, neutralizing activity, avidity and IgG subclasses.
    Scherpenisse M; Schepp RM; Mollers M; Meijer CJ; Berbers GA; van der Klis FR
    PLoS One; 2013; 8(9):e74797. PubMed ID: 24058629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplexed serologic assay for nine anogenital human papillomavirus types.
    Opalka D; Matys K; Bojczuk P; Green T; Gesser R; Saah A; Haupt R; Dutko F; Esser MT
    Clin Vaccine Immunol; 2010 May; 17(5):818-27. PubMed ID: 20237197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types.
    Roberts C; Green T; Hess E; Matys K; Brown MJ; Haupt RM; Luxembourg A; Vuocolo S; Saah A; Antonello J
    Hum Vaccin Immunother; 2014; 10(8):2168-74. PubMed ID: 25424920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between ELISA and pseudovirion-based neutralisation assay for detecting antibodies against human papillomavirus acquired by natural infection or by vaccination.
    Zhao H; Lin ZJ; Huang SJ; Li J; Liu XH; Guo M; Zhang J; Xia NS; Pan HR; Wu T; Li CG
    Hum Vaccin Immunother; 2014; 10(3):740-6. PubMed ID: 24384608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplex immunoassay to measure antibody response to nine HPV vaccine types.
    Panicker G; Rajbhandari I; Pathak HN; Brady AM; Unger ER
    J Immunol Methods; 2021 Nov; 498():113136. PubMed ID: 34464605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of a human papillomavirus-specific enzyme-linked immunosorbent assay.
    Karem KL; Poon AC; Bierl C; Nisenbaum R; Unger E
    Clin Diagn Lab Immunol; 2002 May; 9(3):577-82. PubMed ID: 11986263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of IgG avidity against pertussis toxin and filamentous hemagglutinin via an adapted enzyme-linked immunosorbent assay (ELISA) using ammonium thiocyanate.
    Almanzar G; Ottensmeier B; Liese J; Prelog M
    J Immunol Methods; 2013 Jan; 387(1-2):36-42. PubMed ID: 23022630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of immunoglobulin IgA and IgG against human papilloma virus.
    Gonçalves AK; Machado PR; de Souza LC; Costa AP; Gimenes F; Consolaro ML; Crispim JO; Eleutério J; Giraldo PC
    Viral Immunol; 2014 Nov; 27(9):471-7. PubMed ID: 25191973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed dosing intervals for quadrivalent human papillomavirus vaccine do not reduce antibody avidity.
    Brady AM; Walter EB; Markowitz LE; Unger ER; Panicker G
    Hum Vaccin Immunother; 2020 Aug; 16(8):1802-1807. PubMed ID: 31967933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of type-specific immunoassays to evaluate the functional immune response to Gardasil: a vaccine for human papillomavirus types 16, 18, 6 and 11.
    Smith JF; Kowalski R; Esser MT; Brown MJ; Bryan JT
    Hum Vaccin; 2008; 4(2):134-42. PubMed ID: 18388490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18.
    Dias D; Van Doren J; Schlottmann S; Kelly S; Puchalski D; Ruiz W; Boerckel P; Kessler J; Antonello JM; Green T; Brown M; Smith J; Chirmule N; Barr E; Jansen KU; Esser MT
    Clin Diagn Lab Immunol; 2005 Aug; 12(8):959-69. PubMed ID: 16085914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of Human Papillomavirus-Specific Antibodies Using a Pseudovirion-Based ELISA Method.
    Toh ZQ; He L; Chen C; Huang A; Russell FM; Garland SM; Reyburn R; Ratu T; Tuivaga E; Frazer IH; Mulholland EK; Licciardi PV
    Front Immunol; 2020; 11():585768. PubMed ID: 33193410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Response to Human Papillomavirus One Year after Prophylactic Vaccination with AS04-Adjuvanted HPV-16/18 Vaccine: HPV-Specific IgG and IgA Antibodies in the Circulation and the Cervix.
    Ferreira Costa AP; Gonçalves AK; Machado PRL; Souza LBFC; Sarmento A; Cobucci RNO; Giraldo PC; Witkin SS
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2313-2317. PubMed ID: 30141308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History Study.
    Wentzensen N; Rodriguez AC; Viscidi R; Herrero R; Hildesheim A; Ghosh A; Morales J; Wacholder S; Guillen D; Alfaro M; Safaeian M; Burk RD; Schiffman M
    J Infect Dis; 2011 Jul; 204(1):94-102. PubMed ID: 21628663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody avidity measurements in recipients of Cervarix vaccine following a two-dose schedule or a three-dose schedule.
    Boxus M; Lockman L; Fochesato M; Lorin C; Thomas F; Giannini SL
    Vaccine; 2014 May; 32(26):3232-6. PubMed ID: 24731816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a human papillomavirus (HPV) multiplex immunoassay to profile HPV antibodies.
    Quang C; Chung AW; Kemp TJ; Ratu T; Tuivaga E; Russell FM; Licciardi PV; Toh ZQ
    J Med Virol; 2024 Jun; 96(6):e29732. PubMed ID: 38874202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and evaluation of multiplexed immunoassay for detection of antibodies to HPV vaccine types.
    Panicker G; Rajbhandari I; Gurbaxani BM; Querec TD; Unger ER
    J Immunol Methods; 2015 Feb; 417():107-114. PubMed ID: 25554636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The humoral response to Gardasil over four years as defined by total IgG and competitive Luminex immunoassay.
    Brown DR; Garland SM; Ferris DG; Joura E; Steben M; James M; Radley D; Vuocolo S; Garner EI; Haupt RM; Bryan JT
    Hum Vaccin; 2011 Feb; 7(2):230-8. PubMed ID: 21307649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.